![]() | Up a level |
Journal Article
Schliesser, Maximilian Georg, Claus, Rainer ORCID: 0000-0003-2617-8766, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter
ORCID: 0000-0003-3894-5053, Schramm, Johannes, Sahm, Felix
ORCID: 0000-0001-5441-1962, Weiss, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick
ORCID: 0000-0003-3897-214X, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Hartmann, Christian, Pietsch, Torsten, Felsberg, Joerg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
ORCID: 0000-0002-5863-540X, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
ORCID: 0000-0002-4746-887X, Weller, Michael
ORCID: 0000-0002-1748-174X, Plass, Christoph and Wick, Wolfgang
ORCID: 0000-0002-6171-634X
(2016).
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget, 7 (50).
S. 82028 - 82046.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias
ORCID: 0000-0002-0788-0317, Schuss, Patrick
ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank
ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias
(2022).
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials, 23 (1).
LONDON:
BMC.
ISSN 1745-6215
von Baumgarten, Louisa, Brucker, David, Tirniceru, Anca, Kienast, Yvonne, Grau, Stefan, Burgold, Steffen, Herms, Jochen and Winkler, Frank ORCID: 0000-0003-4892-6104
(2011).
Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells.
Clin. Cancer Res., 17 (19).
S. 6192 - 6206.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1078-0432